DGAP-News: CEVEC's license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP® Ad Technology-produced gene therapy vector in liver cancer patients

DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Miscellaneous CEVEC’s license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP® Ad Technology-produced gene therapy vector in liver cancer patients 13.07.2022 / 14:00 The issuer is solely responsible for the cont...

Related Keywords

Germany ,Nicole Faust ,Ulrich Kettling ,Seong Wook Lee ,Rznomics Inc ,Mc Services ,Korean Ministry Of Food ,Linkedin ,Twitter ,Drug Administration ,Icad Technology ,Distribution Services ,Pharmaceuticals Gmbh Key ,Pharmaceuticals Gmb ,Korean Ministry ,Drug Safety ,South Korean Ministry ,Investigational New Drug ,Biologics Master File ,Cell Banks ,Corporate News ,Regulatory Announcements ,Dgap News ,Levec ,Pharmaceuticals ,Mbh ,Key ,Iscellaneous ,Evec S ,Znomics ,Nc ,Tap ,D ,Technology Produced ,The ,